Pediatr. praxi. 2011;12(5):306-308

Current approach to antiasthmatic therapy in very small children

MUDr.Katarína Beránková
Oddělení respiračních nemocí, Pediatrická klinika 2. LF UK a Fakultní nemocnice v Motole, Praha

Bronchial asthma belongs to the most common chronic diseases that every paediatrician sees almost daily. As the symptomatology and

long-term course of this disease in different periods of childhood is very variable, the decisions about therapeutic strategies are quite

complicated. Until recently we did not have specific guidelines for the treatment of paediatric asthma, so the therapy was usually guided

by the guidelines for adult asthmatics and was individually adjusted for particular patient. Two years after the Practall initiative document

was published (2007) the Global initiative for asthma issued the guidelines for the treatment of asthma in children of five years of age

and younger. This article summarizes current guidelines based on the results of the international randomized studies.

Keywords: asthma, Asthma predictive index, inhaled corticosteroids, leukotriene modifiers

Published: November 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Beránková K. Current approach to antiasthmatic therapy in very small children. Pediatr. praxi. 2011;12(5):306-308.
Download citation

References

  1. Bacharier LB, Boner A, Carlsen KH, et al. Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy 2008; 63: 5-34. Go to original source... Go to PubMed...
  2. Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. Eur Respir J 2008; 32: 1096-1110. Go to original source... Go to PubMed...
  3. Jartti T, Kuusipalo H, Vuorinen T, et al. Allergic sensitization is associated with rhinovirus, but not other virus-, induced wheezing in children. Pediatr Allergy Immunol. 2010; 21(7): 1008-1014. Go to original source... Go to PubMed...
  4. Castro-Rodriguez JA, Holberg CJ, Wrigt AL, et al. A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med 2000; 162: 1403-1406. Go to original source... Go to PubMed...
  5. Castro-Rodriguez JA. The Asthma Predictive Index: A very useful tool for predicting asthma in young children. J Allergy Clin Immunol 2010; 126(2): 212-216. Go to original source... Go to PubMed...
  6. Global Initiative for Asthma: Global Strategy for Asthma Management and Prevention in Children 5 Years and Younger. 2009. Available at www.ginasthma.org.
  7. Ducharme FM, Lemire C, Nova FJ, et al. Randomised controlled trial of intermittent high-dose fluticasone versus placebo in young children with virus-induced asthma. Am J Respir Crit Care Med 2007; 175(Suppl 1): A958.
  8. Bisgaard H, Hermansen MN, Loland L, et al. Intermittent inhaled corticosteroids in infants with episodic wheezing. N Engl J Med 2006; 354: 1998-2005. Go to original source... Go to PubMed...
  9. Murray CS, Woodcock A, Langley SJ, et al. Secondary prevention of asthma by the use of Inhaled Fluticasone propionate in Wheezy INfants (IFWIN): double-blind, randomised controlled study. Lancet 2006; 368: 754-762. Go to original source... Go to PubMed...
  10. Wang L, Hollenbeak CS, Mauger DT, et al. Cost-effectiveness analysis of fluticasone versus montelukast in children with mild-to-moderate persistent asthma in the Pediatric Asthma Controller Trial. J Allergy Clin Immunol. 2011; 127(1): 161-166. Go to original source... Go to PubMed...
  11. Knuffman JE, Sorkness CA, Lemanske RF, et al. Phenotypic predictors of long-term response to inhaled corticosteroid and leukotriene modifier therapies in pediatric asthma. J Allergy Clin Immunol. 2009; 123(2): 411-416. Go to original source... Go to PubMed...




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.